unknown
Stage
About
Euclises develops targeted cancer therapies that prevent tumor immune evasion and kill cancer by disrupting the tumor microenvironment, focusing on selecting patients and optimizing treatment efficacy.
Explore Euclises's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.